Literature DB >> 21135544

Specific removal of C-reactive protein by apheresis in a porcine cardiac infarction model.

Anna Christine Slagman1, Christopher Bock, Hassan Abdel-Aty, Birgit Vogt, Frank Gebauer, Gunnar Janelt, Franziska Wohlgemuth, Rene Morgenstern, Gülcan Yapici, Astrid Puppe, Diethelm Modersohn, Dörte Mans, Timo Jerichow, Sascha Ott, Rudolf Kunze, Wieland Schrödl, Christina Janko, Martin Hermann, Joachim R Kalden, Peter Kern, Hans Parsch, Michael Kirschfink, Jeanette Schulz-Menger, Rainer Röttgen, Juliane K Unger, Ulrich Frei, Ralf Schindler, Martin Möckel, Ahmed Sheriff.   

Abstract

BACKGROUND: C-reactive protein (CRP) is a possible causative factor of the destructive processes observed during the weeks after myocardial infarction.
METHODS: We developed a clinically relevant animal model including the removal of CRP from blood plasma utilizing a specific CRP adsorber and the visualization of the infarct scar in the living animal by cardiovascular magnetic resonance imaging as a tool to investigate the impact of CRP after acute myocardial infarction.
RESULTS: We describe the facets of this model system and kinetics of clinical blood parameters like CRP and troponin. In addition, we demonstrate the potency of CRP apheresis reducing CRP levels by ~70% in the established treatment system.
CONCLUSION: We showed for the first time that it is possible to conduct apheresis at the following 2 days after acute myocardial infarction in a porcine infarction model and to analyze the infarct by cardiovascular magnetic resonance imaging at day 1 and 14.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21135544     DOI: 10.1159/000320763

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  10 in total

Review 1.  Rationale of Hemoadsorption during Extracorporeal Membrane Oxygenation Support.

Authors:  L Christian Napp; Stephan Ziegeler; Detlef Kindgen-Milles
Journal:  Blood Purif       Date:  2019-05-16       Impact factor: 2.614

2.  Association Between Inflammatory Markers and Myocardial Fibrosis.

Authors:  Mateus D Marques; Victor Nauffal; Bharath Ambale-Venkatesh; Henrique D Vasconcellos; Colin Wu; Hossein Bahrami; Russell P Tracy; Mary Cushman; David A Bluemke; João A C Lima
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

3.  Prediction of Infarct Transmurality From C-Reactive Protein Level and Mean Platelet Volume in Patients With ST-Elevation Myocardial Infarction: Comparison of the Predictive Values of Cardiac Enzymes.

Authors:  DongHun Kim; Dong-Hyun Choi; Bo-Bae Kim; Seo-Won Choi; Keun Ho Park; Heesang Song
Journal:  J Clin Lab Anal       Date:  2016-04-13       Impact factor: 2.352

Review 4.  Inflammatory processes in cardiovascular disease: a route to targeted therapies.

Authors:  Neil Ruparelia; Joshua T Chai; Edward A Fisher; Robin P Choudhury
Journal:  Nat Rev Cardiol       Date:  2016-12-01       Impact factor: 32.419

5.  First-in-Man: Case Report of Selective C-Reactive Protein Apheresis in a Patient with SARS-CoV-2 Infection.

Authors:  Jan Torzewski; Franz Heigl; Oliver Zimmermann; Florian Wagner; Christian Schumann; Reinhard Hettich; Christopher Bock; Stefan Kayser; Ahmed Sheriff
Journal:  Am J Case Rep       Date:  2020-07-14

6.  "First in Man": Case Report of Selective C-Reactive Protein Apheresis in a Patient with Acute ST Segment Elevation Myocardial Infarction.

Authors:  Wolfgang Ries; Ahmed Sheriff; Franz Heigl; Oliver Zimmermann; Christoph D Garlichs; Jan Torzewski
Journal:  Case Rep Cardiol       Date:  2018-11-06

7.  Extracellular vesicles are associated with C-reactive protein in sepsis.

Authors:  Birgit Fendl; René Weiss; Tanja Eichhorn; Ingrid Linsberger; Taras Afonyushkin; Florian Puhm; Christoph J Binder; Michael B Fischer; Viktoria Weber
Journal:  Sci Rep       Date:  2021-03-26       Impact factor: 4.379

Review 8.  The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.

Authors:  Mark B Pepys
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

Review 9.  Selective Apheresis of C-Reactive Protein for Treatment of Indications with Elevated CRP Concentrations.

Authors:  Stefan Kayser; Patrizia Brunner; Katharina Althaus; Johannes Dorst; Ahmed Sheriff
Journal:  J Clin Med       Date:  2020-09-12       Impact factor: 4.241

Review 10.  [CRP apheresis in acute myocardial infarction and COVID-19].

Authors:  Michael Buerke; Ahmed Sheriff; Christoph D Garlichs
Journal:  Med Klin Intensivmed Notfmed       Date:  2022-03-25       Impact factor: 1.552

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.